---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-095819"
form_type: "8-K"
ticker: "NRIX"
cik: "0001549595"
company_name: "Nurix Therapeutics, Inc."
filed_at: "2023-04-10T23:59:59+00:00"
generated_at: "2026-06-17T04:06:51.639763+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nurix Therapeutics COO Stefani A. Wolff resigns, effective May 2, 2023

## Summary
- Stefani A. Wolff notified resignation as COO and EVP of Product Development on April 5, 2023.
- Departure effective May 2, 2023; no successor announced.
- Wolff oversaw product development and operations; departure creates a senior management void.

## SEC filing metadata
- accession: 0001193125-23-095819
- form_type: 8-K
- ticker: NRIX
- cik: 0001549595
- company_name: Nurix Therapeutics, Inc.
- filed_at: 2023-04-10T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549595/000119312523095819/0001193125-23-095819-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549595/000119312523095819/d495127d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-095819
- JSON: https://secwatch.observer/filing/0001193125-23-095819.json
- Plain text: https://secwatch.observer/filing/0001193125-23-095819.txt

## Key facts
- Executive change
  Stefani A. Wolff resigned as Chief Operating Officer and Executive Vice President of Product Development at Nurix Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Operating Officer and Executive Vice President of Product Development
  source text: On April 5, 2023, Stefani A. Wolff notified Nurix Therapeutics, Inc. (“Nurix”) of her decision to resign from her position as Chief Operating Officer and Executive Vice President of Product Development of Nurix, effective May 2, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549595/000119312523095819/0001193125-23-095819-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.